New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareSemaglutide vs Tripeptide-29

Semaglutide vs Tripeptide-29

Side-by-side comparison of key properties, dosing, and research.

GLP-1 / Weight Loss Agonists
Semaglutide
Skin & CosmeticAnti-Aging & Longevity
Tripeptide-29
Summary
Semaglutide is an FDA-approved GLP-1 receptor agonist originally developed for type 2 diabetes that has proven remarkably effective for weight loss. Clinical trials show average 15–20% body weight reduction. It is marketed as Ozempic (diabetes) and Wegovy (weight management).
Tripeptide-29 is a pro-collagen cosmetic peptide composed of proline, hydroxyproline, and glycine — the core repeating unit of collagen. Applied topically, it signals dermal fibroblasts that collagen degradation has occurred, triggering compensatory new collagen synthesis.
Half-Life
~7 days
Not applicable (topical)
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg
0.01-0.1% in formulation
Frequency
Once weekly, subcutaneous
Once or twice daily
Key Benefits
  • Average 15–20% body weight reduction in clinical trials (STEP trials)
  • Significant reduction in appetite and food cravings
  • Improvement in blood sugar control and insulin sensitivity
  • Reduces cardiovascular risk (SELECT trial: 20% reduction in MACE)
  • May reduce risk of kidney disease
  • Improves metabolic markers (cholesterol, blood pressure)
  • FDA-approved — extensively studied with robust safety data
  • Weekly dosing convenience
  • Stimulates fibroblast collagen synthesis via damage-signal mechanism
  • Reduces fine lines and improves skin smoothness
  • Supports dermal matrix integrity
  • Naturally bioidentical to collagen fragment sequences
  • Well-tolerated in all skin types
  • Synergistic with copper peptides and retinoids
Side Effects
  • Nausea (most common, especially during titration)
  • Vomiting
  • Diarrhea or constipation
  • Abdominal discomfort
  • +4 more
  • Excellent tolerability profile
  • No documented significant adverse effects at cosmetic concentrations
  • Rare sensitivity reactions in individuals with peptide allergies
Stacks With